SALVADOR LOPEZ: Open Payments
NPI 1649726852 · YAKIMA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,575 in 99 payments from 22 companies in 2025. Trend: 2023 $7,261 · 2024 $2,364 · 2025 $2,575
Food & beverage: $2,575
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 17 | $843 |
| PFIZER INC. | 18 | $357 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $151 |
| Abbott Laboratories | 6 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $129 |
| Exact Sciences Corporation | 6 | $124 |
| ABBVIE INC. | 4 | $101 |
| Corcept Therapeutics | 4 | $81 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $80 |
| Novo Nordisk Inc | 4 | $75 |
Products named: FARXIGA, ELIQUIS, CAPLYTA, FREESTYLE LIBRE 3, NURTEC ODT, AIRSUPRA, Kerendia, BREZTRI.
Industry payments across WA — which companies pay providers there.
